Update of phase I study of Imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group.

AT van Oosterom; IR Judson; Jaap Verweij; S Stroobants; H Dumez; E Donato di Paola; R Sciot; M Glabbeke; S Dimitrijevic; OS Nielsen

Update of phase I study of Imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group.

AT van Oosterom, IR Judson, Jaap Verweij, S Stroobants, H Dumez, E Donato di Paola, R Sciot, M Glabbeke, S Dimitrijevic, OS Nielsen

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

211 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	83-87
Number of pages	5
Journal	European Journal of Cancer
Volume	38
Issue number	5
Publication status	Published - 2002

Cite this

van Oosterom, AT., Judson, IR., Verweij, J., Stroobants, S., Dumez, H., Donato di Paola, E., Sciot, R., Glabbeke, M., Dimitrijevic, S., & Nielsen, OS. (2002). Update of phase I study of Imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group. European Journal of Cancer, 38(5), 83-87.

@article{411d3ceec81d4c61b042fae5be351ef9,

title = "Update of phase I study of Imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group.",

author = "{van Oosterom}, AT and IR Judson and Jaap Verweij and S Stroobants and H Dumez and {Donato di Paola}, E and R Sciot and M Glabbeke and S Dimitrijevic and OS Nielsen",

year = "2002",

language = "Undefined/Unknown",

volume = "38",

pages = "83--87",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

number = "5",

}

van Oosterom, AT, Judson, IR, Verweij, J, Stroobants, S, Dumez, H, Donato di Paola, E, Sciot, R, Glabbeke, M, Dimitrijevic, S & Nielsen, OS 2002, 'Update of phase I study of Imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group.', European Journal of Cancer, vol. 38, no. 5, pp. 83-87.

Update of phase I study of Imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group. / van Oosterom, AT; Judson, IR; Verweij, Jaap et al.

In: European Journal of Cancer, Vol. 38, No. 5, 2002, p. 83-87.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Update of phase I study of Imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group.

AU - van Oosterom, AT

AU - Judson, IR

AU - Verweij, Jaap

AU - Stroobants, S

AU - Dumez, H

AU - Donato di Paola, E

AU - Sciot, R

AU - Glabbeke, M

AU - Dimitrijevic, S

AU - Nielsen, OS

PY - 2002

Y1 - 2002

M3 - Article

VL - 38

SP - 83

EP - 87

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 5

ER -